|
|
This issue is sponsored by the Southeast Lipid Association.
Featuring: "Cardiovascular Nutrition Fads and Controversies" and "How Shall We Eat? The Challenging Task of Evidence-Based Nutrition"
|
|
|
This issue is sponsored by the Southwest Lipid Association.
Featuring: "Improving Care Through Collaboration" and "FOURIER Analysis – The Waves of Data to Roll-In"
|
|
|
Featuring "Emerging Technologies And Therapeutics In Clinical Lipidology" and "Letters from the Editors – Past & Present"
|
|
|
This issue is sponsored by the Pacific Lipid Association.
Featuring: "Targeting Atherogenic Cholesterol Goals for Patients that Meet the Criteria of ‘Extreme’ ASCVD Risk" and "The Lipid and Cardiovascular Disease Specialist and the Use of Basic Statistics: Reader Beware"
|
|
|
This issue sponsored by the Midwest Lipid Association
Featuring: “The Use of Statins to Reduce Cardiovascular Risk in the Elderly” and "Age-Related Pharmacokinetic Changes and the Impact on Statin Therapy in Older Patients"
|
|
|
This issue sponsored by the National Lipid Association
Featuring: “Search for the Secondary Cause: Worth the Pause” and "Clinical Conundrum: The Estimated LDL-C Below 40 mg/dL"
|
|
|
This issue sponsored by the Northeast Lipid Association
Featuring: "The Continuing Saga of HDL: Truth, Fallacy, or Something in Between?" and "Nutrition Recommendations and Disorders of Lipid Metabolism: Untangling the Confusion among Consumers and Healthcare Providers"
|
|
|
This issue sponsored by the Southeast Lipid Association
Featuring: "Dyslipidemia & Antipsychotic Medications: Who is Monitoring the Lipids?" and "Specialized Use of a Niacin-Statin Combination in Lipid Management"
|
|
|
This issue sponsored by the Southwest Lipid Association
Featuring: "Why Advocacy is Important to a Medical Specialty Organization" and "Beyond the Guidelines: Application of Trial Data to Individual Patients by Focusing on Explanatory vs Pragmatic Trials"
|
|
|
This issue sponsored by the Pacific Lipid Association
Featuring: "PCSK9 Monoclonal Antibody Therapy – The Latest Data and Who is Appropriate for Treatment" and "Tuberous and Tendon Xanthomas: Don’t Overlook Sitosterolemia or Cerebrotendinous Xanthomatosis"
|
.jpg)
